Kevin Heal

Stock Analyst at Argus Research

(2.85)
# 1,361
Out of 4,810 analysts
46
Total ratings
51.61%
Success rate
4.84%
Average return

Stocks Rated by Kevin Heal

Nasdaq
Nov 5, 2024
Maintains: Buy
Price Target: $76$82
Current: $73.17
Upside: +12.07%
Regions Financial
Oct 24, 2024
Upgrades: Buy
Price Target: $26
Current: $19.43
Upside: +33.81%
Zions Bancorporation, National Association
Jul 25, 2024
Downgrades: Hold
Price Target: n/a
Current: $43.79
Upside: -
Huntington Bancshares
Jul 22, 2024
Maintains: Buy
Price Target: $15$16
Current: $13.40
Upside: +19.40%
MetLife
May 22, 2024
Maintains: Buy
Price Target: $77$80
Current: $72.71
Upside: +10.03%
Intercontinental Exchange
May 21, 2024
Reiterates: Buy
Price Target: $153
Current: $159.95
Upside: -4.35%
Ameriprise Financial
May 6, 2024
Maintains: Buy
Price Target: $440$460
Current: $476.44
Upside: -3.45%
Citizens Financial Group
Apr 24, 2024
Maintains: Buy
Price Target: $36$39
Current: $36.10
Upside: +8.03%
CME Group
Mar 6, 2024
Maintains: Buy
Price Target: $225$245
Current: $262.87
Upside: -6.80%
Rithm Capital
Mar 5, 2024
Maintains: Buy
Price Target: $11$12
Current: $10.13
Upside: +18.46%
Downgrades: Hold
Price Target: n/a
Current: $52.99
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $217.84
Upside: -
Upgrades: Hold
Price Target: n/a
Current: $12.50
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $17.96
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $8.41
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $4.59
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $194.54
Upside: -
Upgrades: Buy
Price Target: $185
Current: $284.80
Upside: -35.04%